Internal Medicine, Gastroenterology · Osage Beach, MO
NPI
1326020082
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1029 Nichols Rd Ste 201
Osage Beach, MO, 65065
Phone (573) 302-7138
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
1,794 services
Medicare patients, 2024
971
Average age 73
Drug cost, 2024
$1.8M
4,835 prescriptions
Company payments, 2025
$2,013
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin G Byrne was code 99213 (office e&m - established), 562 times for 393 patients. In total Kevin G Byrne billed 1,794 services in 48 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 562 | 393 | $52.27 | $29K |
| 43239 Upper GI Endoscopy | Facility | 260 | 248 | $67.01 | $17K |
| 45385 Colonoscopy - Lesion Removal | Facility | 177 | 174 | $182.91 | $32K |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 102 | 102 | $159.77 | $16K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 78 | 78 | $159.86 | $12K |
| 99203 Office E&M - New | Office | 72 | 72 | $62.17 | $4,476 |
| 45380 Lower GI Endoscopy - Other | Facility | 64 | 64 | $107.83 | $6,901 |
| 45378 Lower GI Endoscopy - Other | Facility | 63 | 63 | $120.50 | $7,592 |
| 99221 Hospital E&M - Initial | Facility | 46 | 45 | $57.74 | $2,656 |
| 99231 Hospital E&M - Subsequent | Facility | 34 | 23 | $34.70 | $1,180 |
| 43249 Upper GI Endoscopy | Facility | 31 | 28 | $91.59 | $2,839 |
| 43450 Digestive/Gastrointestinal | Facility | 30 | 29 | $27.73 | $832 |
| 99204 Office E&M - New | Office | 23 | 23 | $102.42 | $2,356 |
| 43235 Upper GI Endoscopy | Facility | 22 | 20 | $79.17 | $1,742 |
| 99214 Office E&M - Established | Office | 21 | 21 | $71.27 | $1,497 |
By year: 2022 $152K for 1,773 services; 2023 $156K for 1,801 services; 2024 $157K for 1,794 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin G Byrne prescribed most often to Medicare patients was Pantoprazole Sodium, with 816 prescriptions and refills. In total Kevin G Byrne wrote 4,835 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 816 | 1,645 | 230 | $7,275 |
| Famotidine Generic | 444 | 855 | 116 | $4,205 |
| Omeprazole Generic | 353 | 759 | 106 | $4,521 |
| Sucralfate Generic | 333 | 538 | 106 | $9,816 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 297 | 297 | 292 | $4,513 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 289 | 289 | 279 | $4,429 |
| Linzess Linaclotide | 229 | 343 | 63 | $184K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 160 | 160 | 159 | $10K |
| Metoclopramide Hcl Generic | 146 | 185 | 54 | $822 |
| Colestipol Hcl Generic | 95 | 124 | 28 | $6,658 |
| Lubiprostone Generic | 94 | 116 | 24 | $8,420 |
| Dicyclomine Hcl Generic | 93 | 116 | 32 | $1,322 |
| Lansoprazole Generic | 77 | 124 | 20 | $2,133 |
| Ursodiol Generic | 63 | 135 | 14 | $7,173 |
| Esomeprazole Magnesium Generic | 59 | 98 | 13 | $2,471 |
Brand drugs: 1,168 claims; generic drugs: 3,667 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin G Byrne $2,013 ($2,013 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $462.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 33 | $462 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $229 |
| Gilead Sciences, Inc. GILD | 24 | $212 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $182 |
| Janssen Biotech, Inc. JNJ | 8 | $163 |
| Madrigal Pharmaceuticals MDGL | 7 | $116 |
| Ardelyx, Inc. ARDX | 7 | $110 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $94.52 |
| Aimmune Therapeutics, Inc. | 4 | $92.44 |
| Genzyme Corporation SNY | 3 | $88.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.